Pharmacielo Ltd (PCLO) - Total Assets
Based on the latest financial reports, Pharmacielo Ltd (PCLO) holds total assets worth CA$8.64 Million CAD (≈ $6.25 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Pharmacielo Ltd (PCLO) net assets for net asset value and shareholders' equity analysis.
Pharmacielo Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Pharmacielo Ltd's total assets have evolved over time, based on quarterly financial data.
Pharmacielo Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Pharmacielo Ltd's total assets of CA$8.64 Million consist of 13.2% current assets and 86.8% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0.8% |
| Accounts Receivable | CA$343.98K | 1.9% |
| Inventory | CA$1.50 Million | 8.2% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Pharmacielo Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Pharmacielo Ltd (PCLO) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pharmacielo Ltd's current assets represent 13.2% of total assets in 2024, a decrease from 36.4% in 2016.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2024, down from 34.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 8.2% of total assets.
Pharmacielo Ltd Competitors by Total Assets
Key competitors of Pharmacielo Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.15 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥10.58 Billion |
Pharmacielo Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.15 | 0.15 | 2.81 |
| Quick Ratio | 0.09 | 0.07 | 1.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-20.03 Million | CA$-19.38 Million | CA$7.41 Million |
Pharmacielo Ltd - Advanced Valuation Insights
This section examines the relationship between Pharmacielo Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.48 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | -17.5% |
| Total Assets | CA$18.39 Million |
| Market Capitalization | $8.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pharmacielo Ltd's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Pharmacielo Ltd's assets decreased by 17.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pharmacielo Ltd (2016–2024)
The table below shows the annual total assets of Pharmacielo Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$18.39 Million ≈ $13.31 Million |
-17.48% |
| 2023-12-31 | CA$22.29 Million ≈ $16.12 Million |
-11.25% |
| 2022-12-31 | CA$25.12 Million ≈ $18.17 Million |
-30.15% |
| 2021-12-31 | CA$35.96 Million ≈ $26.01 Million |
-18.33% |
| 2020-12-31 | CA$44.02 Million ≈ $31.85 Million |
-12.30% |
| 2019-12-31 | CA$50.20 Million ≈ $36.31 Million |
+24008.41% |
| 2018-12-31 | CA$208.21K ≈ $150.62K |
+100.85% |
| 2017-12-31 | CA$103.66K ≈ $74.99K |
-99.08% |
| 2016-12-31 | CA$11.22 Million ≈ $8.12 Million |
-- |
About Pharmacielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more